Medical Oncology

Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: Accumulating evidence for synergy, efficacy, and safety
pp. 147-160(14)
Authors: Pentheroudakis, G.; Razis, E.; Athanassiadis, A.; Pavlidis, N.; Fountzilas, G.

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors
pp. 161-170(10)
Authors: Tsuboi, Masahiro; Chevalier, Thierry

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
pp. 171-183(13)
Authors: Fernández-Sánchez, Mónica; Gamboa-Dominguez, Armando; Uribe, Norma; García-Ulloa, Ana; Flores-Estrada, Diana; Candelaria, Myrna; Arrieta, Oscar

Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer: A randomized prospective clinical trial
pp. 185-189(5)
Authors: Misirliogluo, Cem; Erkal, Handan; Elgin, Yesim; Ugur, Isil; Altundag, Kadri

Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC)
pp. 191-204(14)
Authors: Yang, F.; Shi, P.; Xi, X.; Yi, S.; Li, H.; Sun, Q.; Sun, M.

Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer
pp. 205-212(8)
Authors: Hashiguchi, Yasunori; Tsuda, Hiroshi; Bandera, Christina; Nishimura, Sadako; Inoue, Takeshi; Kawamura, Naoki; Berkowitz, Ross; Mok, Samuel

The value of serum bcl-2 levels in advanced epithelial ovarian cancer
pp. 213-217(5)
Authors: Tas, Faruk; Duranyildiz, Derya; Oguz, Hilal; Camlica, Hakan; Yasasever, Vildan; Topuz, Erkan

Pelvic exenteration for recurrent or persistent cervical cancer: Experience of Five Years at the National Cancer Institute in Mexico
pp. 219-223(5)
Authors: Terán-Porcayo, M.; Zeichner-Gancz, I.; Gomez del-Castillo, R.; Beltrán-Ortega, A.; Solorza-Luna, G.

Primary extranodal lymphomas of gastrointestinal localizations: A single institution 5-yr experience
pp. 225-235(11)
Authors: Mihaljević, B.; Nedeljkov-Jančić, R.; Vujičić, V.; Antić, D.; Janković, S.; Čolović, N.

Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer
pp. 237-244(8)
Authors: Nasif, Wesam; Lotfy, Mahmoud; El-Sayed, Ibrahim; El-Kenawy, Ayman; El-Shahat, Mohamed; El-Hak, Nabil

Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro
pp. 245-250(6)
Authors: Waheed Roomi, M.; Ivanov, Vadim; Kalinovsky, Tatiana; Niedzwiecki, Aleksandra; Rath, Matthias

Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: A prospective randomized open label study in cancer patients
pp. 251-262(12)
Authors: Mystakidou, K.; Katsouda, E.; Linou, A.; Parpa, E.; Kouloulias, V.; Nikolaou, V.; Vlahos, L.

Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: A phase 2 trial
pp. 263-272(10)
Authors: Abou-Jawde, Rony; Reed, Janice; Kelly, Megan; Walker, Esteban; Andresen, Steven; Baz, Rachid; Karam, Mary; Hussein, Mohamad

Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells
pp. 273-282(10)
Authors: Mahdian, Reza; Kokhaei, Parviz; Najar, Hossein; Derkow, Katja; Choudhury, Aniruddha; Mellstedt, Håkan

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)
pp. 283-293(11)
Authors: Adde, Magdalena; Enblad, Gunilla; Hagberg, Hans; Sundström, Christer; Laurell, Anna

Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma
pp. 295-300(6)
Authors: Avilés, Agustín; Neri, Natividad; Nambo, M.; Huerta-Guzman, Judith; Cleto, Sergio

Uterine choriocarcinoma in a postmenopausal woman
pp. 301-303(3)
Authors: Mukherjee, U.; Thakur, V.; Katiyar, D.; Goyal, Hari; Pendharkar, D.